Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-11-22

Clinical Trial Update: Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

View source ↗

Summary

This clinical trial update describes a real-world screening study and registry to monitor tardive dyskinesia in patients taking antipsychotic medications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Neurocrine Biosciences | Conditions: Tardive Dyskinesia | Status: UNKNOWN